Antiarrhythmics
High-yield Verified · Jul 2026Prototype: amiodarone
Antiarrhythmics are a class of medications used to treat atrial fibrillation / flutter.
Agents that modify cardiac conduction, grouped by the Vaughan-Williams classification (I–IV).
How it works in the body
The system involved, what goes wrong, and how the drug and body interact.
01 The heartbeat is electrical — the cardiac action potential
Every heartbeat starts as an electrical impulse. In each cardiac cell, ions flow across the membrane in a set sequence that makes up the action potential: sodium (Na⁺) rushes in to fire the impulse (depolarization), calcium (Ca²⁺) sustains it and drives contraction, and potassium (K⁺) flows out to reset the cell (repolarization). The pacemaker (SA node) sets the rate; the AV node gates how fast impulses pass to the ventricles.
An arrhythmia is this orderly sequence going wrong — the heart beating too fast, too slow, or chaotically (as in atrial fibrillation), often from an abnormal focus firing or an impulse looping back on itself (re-entry). Antiarrhythmics work by adjusting the very ion channels that shape the action potential.
02 The four Vaughan-Williams classes
Antiarrhythmics are grouped by which ion channel they block — the Vaughan-Williams classification. Class I blocks sodium channels (slowing the initial upstroke; e.g. flecainide, lidocaine). Class II are the beta-blockers, which slow the SA/AV nodes via the sympathetic system. Class III blocks potassium channels, prolonging repolarization (e.g. sotalol, and amiodarone). Class IV are the non-dihydropyridine calcium channel blockers (diltiazem, verapamil), slowing AV conduction.
Amiodarone is the exception that proves the rule: it shows properties of all four classes at once. That broad action makes it highly effective — and, as the side effects show, uniquely toxic. Adenosine sits outside the classification: it briefly blocks the AV node to stop a re-entrant SVT.
03 The paradox — and the price of amiodarone
Antiarrhythmics carry a built-in paradox: a drug that alters the heart’s electrical timing to *fix* one arrhythmia can create another. This is proarrhythmia. Class III agents (and others) prolong the QT interval, which can trigger a dangerous rhythm called torsades de pointes — so the QT is watched closely.
Amiodarone’s all-class potency comes at a cost seen nowhere else: because it is fat-soluble and stored in tissues with an extremely long half-life (weeks to months), it accumulates in the lungs (fibrosis), liver, thyroid (it is iodine-rich → hypo- or hyperthyroidism), eyes, and skin (blue-gray discoloration, photosensitivity). These slow, cumulative toxicities are the reason for its boxed warning and its intensive monitoring schedule.
Drug names
Indications
- Atrial fibrillation / flutter (rate and rhythm control)
- Ventricular tachycardia / fibrillation (amiodarone, lidocaine)
- Termination of paroxysmal SVT (adenosine)
Mechanism of action
Alter cardiac ion channels and conduction per the Vaughan-Williams classes: I = sodium-channel blockers, II = beta-blockers, III = potassium-channel blockers (prolong repolarization), IV = non-dihydropyridine calcium channel blockers. Amiodarone shows properties of all four classes.
Therapeutic effects — what you'll see working
The goal is a stable rhythm at a safe rate — confirmed on the ECG/telemetry monitor, not by how the patient feels. Because these drugs can also *cause* arrhythmias, "success" always means watching the rhythm continuously.
- Rhythm control
- Restoring and maintaining normal sinus rhythm by damping abnormal foci or interrupting re-entry circuits — the aim in atrial fibrillation or ventricular tachycardia.
- Rate control
- Slowing AV-node conduction (class II and IV) to bring a rapid ventricular rate down to a safe range, even if the underlying rhythm remains abnormal.
- Terminates SVT (adenosine)
- A rapid IV push of adenosine briefly blocks the AV node — breaking the re-entrant loop of a paroxysmal SVT and often converting it back to sinus rhythm in seconds.
Adverse effects
Two themes run through the whole class: proarrhythmia (a rhythm drug can cause new rhythms, especially via QT prolongation) and, for amiodarone, cumulative multi-organ toxicity from tissue storage.
Interactions
Contraindications
Contraindications are largely class-specific, but the shared theme is a heart that is already too slow or too blocked, or an ECG that is already primed for torsades.
Labs & levels
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
Common questions
What are Antiarrhythmics used for?
How do Antiarrhythmics work?
What are the serious side effects of Antiarrhythmics?
What labs should be monitored with Antiarrhythmics?
See also
Slow heart rate & lower BP by blocking β-adrenergic receptors. Watch for bradycardia.
Lower BP by blocking angiotensin conversion. Classic dry cough & angioedema risk.
Lower LDL cholesterol via HMG-CoA reductase inhibition. Monitor for myopathy.
Prevent clot formation. High-alert medications — bleeding precautions essential.
Relax vessels (dihydropyridines) or slow the heart (non-dihydropyridines). Watch edema & bradycardia.
Offload fluid via the kidney — loop, thiazide & potassium-sparing. Monitor electrolytes closely.
Sources
- Antiarrhythmic Medications — Vaughan-Williams classes, amiodarone boxed warnings — StatPearls (NCBI)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Always verify against current prescribing information and your institution's protocols before administering. Not medical advice.